MX2021004296A - Composiciones de conotoxina del antagonista del peptido receptor nicotinico de acetilcolina y metodos relacionados. - Google Patents

Composiciones de conotoxina del antagonista del peptido receptor nicotinico de acetilcolina y metodos relacionados.

Info

Publication number
MX2021004296A
MX2021004296A MX2021004296A MX2021004296A MX2021004296A MX 2021004296 A MX2021004296 A MX 2021004296A MX 2021004296 A MX2021004296 A MX 2021004296A MX 2021004296 A MX2021004296 A MX 2021004296A MX 2021004296 A MX2021004296 A MX 2021004296A
Authority
MX
Mexico
Prior art keywords
compositions
acetylcholine receptor
nicotinic acetylcholine
conotoxin
peptide antagonist
Prior art date
Application number
MX2021004296A
Other languages
English (en)
Inventor
Robert A Love
Original Assignee
Glo Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glo Pharma Inc filed Critical Glo Pharma Inc
Publication of MX2021004296A publication Critical patent/MX2021004296A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Immunology (AREA)

Abstract

La presente invención está relacionada con antagonistas de péptidos novedosos que inhiben el enlace de la acetilcolina al sitio activo del receptor de acetilcolina tipo muscular. Los antagonistas de péptidos de la invención son útiles es composiciones cosméticas que previenen o mejoran la apariencia de las arrugas de la piel o condiciones de la piel relacionadas. La invención además está relacionada con composiciones cosméticas y farmacéuticas que comprenden un antagonista de péptido de la invención, y métodos para su uso.
MX2021004296A 2018-10-16 2019-10-15 Composiciones de conotoxina del antagonista del peptido receptor nicotinico de acetilcolina y metodos relacionados. MX2021004296A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862746398P 2018-10-16 2018-10-16
US201962867128P 2019-06-26 2019-06-26
PCT/US2019/056360 WO2020081583A1 (en) 2018-10-16 2019-10-15 Nicotinic acetylcholine receptor peptide antagonist conotoxin compositions and related methods

Publications (1)

Publication Number Publication Date
MX2021004296A true MX2021004296A (es) 2021-08-05

Family

ID=70158934

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021004296A MX2021004296A (es) 2018-10-16 2019-10-15 Composiciones de conotoxina del antagonista del peptido receptor nicotinico de acetilcolina y metodos relacionados.

Country Status (12)

Country Link
US (2) US11130782B2 (es)
EP (1) EP3866828A4 (es)
JP (2) JP2022514114A (es)
KR (2) KR20230145516A (es)
CN (1) CN113194977A (es)
AU (1) AU2019361942A1 (es)
BR (1) BR112021007131A2 (es)
CA (1) CA3116315A1 (es)
MA (1) MA53932A (es)
MX (1) MX2021004296A (es)
SG (1) SG11202103791PA (es)
WO (1) WO2020081583A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3866828A4 (en) 2018-10-16 2022-08-31 GLO Pharma, Inc. CONOTOXIN COMPOSITIONS AS NICOTINIC ACETYLCHOLINE RECEPTOR PEPTIDE ANTAGONISTS AND METHODS THEREOF
AU2020351835A1 (en) 2019-09-23 2022-04-14 DSS Research Inc. Lipid vesicle compositions with penetration enhancing agents
KR20240037872A (ko) * 2021-03-24 2024-03-22 글로 파마, 인크. 미용제 전달을 위한 멀티솜 지질 소포
EP4378950A1 (en) * 2021-07-27 2024-06-05 Skinmed Co., Ltd. Optimized shortened peptide that binds to acetylcholine receptor, and use thereof
CN117084934B (zh) * 2023-10-20 2024-01-19 深圳市维琪科技股份有限公司 多肽的新用途

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4447356A (en) * 1981-04-17 1984-05-08 Olivera Baldomero M Conotoxins
JPS615095A (ja) * 1984-06-15 1986-01-10 Ajinomoto Co Inc コノトキシンｍｉ（ｂ）類縁体
US5474796A (en) 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
CA2186371A1 (en) 1994-03-25 1995-10-05 Robert T. Foster Enhancement of the efficacy of dihydropyridines by deuteration
US6334997B1 (en) 1994-03-25 2002-01-01 Isotechnika, Inc. Method of using deuterated calcium channel blockers
AU1114399A (en) * 1997-10-24 1999-05-17 Case Western Reserve University Interaction of alpha-conotoxin peptides with neuronal nicotinic acetylcho line receptors
WO2000043409A2 (en) * 1999-01-22 2000-07-27 University Of Utah Research Foundation Alpha-conotoxin peptides
US6797808B1 (en) 1999-01-29 2004-09-28 University Of Utah Research Foundation α-conotoxin peptides
ES2160485B1 (es) 1999-04-23 2002-05-16 Lipotec Sa Peptidos inhibidores de la exocitosis neuronal, composiciones cosmeticas y farmaceuticas que los contienen.
WO2002007750A1 (en) * 2000-07-20 2002-01-31 Cognetix, Inc. Alpha-conotoxin peptides
US20030109670A1 (en) 2001-02-09 2003-06-12 University Of Utah Research Foundation Cone snail peptides
CA2584643C (en) 2004-11-02 2013-01-29 Pentapharm Ag New, topically applicable actives against mimic and age-related wrinkles
US8043829B2 (en) 2006-10-25 2011-10-25 Amgen Inc. DNA encoding chimeric toxin peptide fusion proteins and vectors and mammalian cells for recombinant expression
EP2250193B1 (en) 2008-02-19 2019-09-18 Myocept Inc. Postsynaptically targeted chemodenervation agents and their methods of use
CN101745097A (zh) * 2008-12-12 2010-06-23 海南大学 特异阻断乙酰胆碱受体的海南产α-芋螺毒素及其用途
RU2473559C1 (ru) 2011-10-26 2013-01-27 Общество с ограниченной ответственностью "Синейро" Пептид аземиопсин, избирательно взаимодействующий с никотиновыми холинорецепторами мышечного типа и пригодный для использования в качестве мышечного релаксанта в медицине и косметологии
WO2013153236A2 (en) * 2012-04-13 2013-10-17 Activen Cosmetic composition comprising a muconopeptide
RU2524428C1 (ru) 2013-01-21 2014-07-27 Общество с ограниченной ответственностью "Синейро" Пептиды и их производные, взаимодействующие с никотиновым ацетилхолиновым рецептором и пригодные для использования в косметологии против мимических и возрастных морщин
CN108367045B (zh) 2015-12-16 2022-01-25 帝斯曼知识产权资产管理有限公司 新用途
EP3866828A4 (en) 2018-10-16 2022-08-31 GLO Pharma, Inc. CONOTOXIN COMPOSITIONS AS NICOTINIC ACETYLCHOLINE RECEPTOR PEPTIDE ANTAGONISTS AND METHODS THEREOF
AU2021254403A1 (en) 2020-04-09 2022-11-10 Glo Pharma, Inc. Peptide compositions and methods for inhibiting nicotinic acetylcholine receptor activity

Also Published As

Publication number Publication date
EP3866828A4 (en) 2022-08-31
CN113194977A (zh) 2021-07-30
JP2023117418A (ja) 2023-08-23
US20220048950A1 (en) 2022-02-17
AU2019361942A1 (en) 2021-06-03
KR20210077724A (ko) 2021-06-25
WO2020081583A1 (en) 2020-04-23
SG11202103791PA (en) 2021-05-28
US20200115414A1 (en) 2020-04-16
KR20230145516A (ko) 2023-10-17
CA3116315A1 (en) 2020-04-23
MA53932A (fr) 2021-08-25
EP3866828A1 (en) 2021-08-25
US11970552B2 (en) 2024-04-30
JP2022514114A (ja) 2022-02-09
US11130782B2 (en) 2021-09-28
BR112021007131A2 (pt) 2021-08-10

Similar Documents

Publication Publication Date Title
MX2021004296A (es) Composiciones de conotoxina del antagonista del peptido receptor nicotinico de acetilcolina y metodos relacionados.
WO2018083087A3 (en) Binding proteins
MX2021007184A (es) Formas cristalinas del derivado de 4-pirimidinsulfamida aprocitentan.
WO2015051030A3 (en) Stabilized polypeptides and uses thereof
WO2016185481A3 (en) Method of targeting senescent cells
EA201690159A1 (ru) Способы и композиции для лечения рака
EA201691836A1 (ru) Антитела к mcam и соответствующие способы их применения
EA201390813A1 (ru) Антитела и их применение
EP3712144A4 (en) P2X3 AND / OR P2X2 / 3 RECEPTOR ANTAGONIST, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF
TR201902686T4 (tr) Aurora A kinaz inhibitörü.
MX2021005085A (es) Formulacion de anticuerpo.
MX2018010546A (es) Metodos de tratamiento de cancer que usan antagonistas de union al eje de muerte programada 1 (pd-1) y anticuerpos anti glipicano 3 (gpc3).
SA519410097B1 (ar) P2x7 مشتقات رباعي هيدروكوينولين كمعارضات مستقبل
SA519401424B1 (ar) Cmet عوامل ربط أحادية النسيلة، مترافقات عقار منها واستخداماتها
MX2019014448A (es) Inmunoglobulinas de enlace a mmp13.
EA201892529A1 (ru) Комбинация чистых антагонистов 5-htрецепторов с ингибиторами ацетилхолинэстеразы
WO2017140684A3 (en) Methods and pharmaceutical compositions for the treatment of post-operative cognitive dysfunction
EA201892583A1 (ru) Комбинация чистых антагонистов 5-htрецептора с антагонистом nmda рецептора
WO2016111523A3 (ko) HNF4-α 길항제 및 이의 용도
EA202190939A1 (ru) Композиции пептидного антагониста никотинового ацетилхолинового рецептора конотоксина и связанные способы
MX2020009305A (es) Uso de un anticuerpo anti-p-selectina.
BR112018016648A2 (pt) peptídeos alfa-conotoxina
BR112022020338A2 (pt) Composições peptídicas e métodos para inibir atividade do receptor nicotínico da acetilcolina
WO2015200768A3 (en) Pharmacologic treatments of menière's disease
MX2022000317A (es) Anticuerpos altamente potentes que se unen al receptor de muerte 4 y al receptor de muerte 5.